drugset / Trial / NCT02444936

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

NCT02444936

RandomizedParallel-groupSingle-blindBasic science

Summary

This study evaluates if the shingles vaccine works in those persons that receive it before they receive chemotherapy for solid organ tumors. Half of the participants will receive the ZOSTAVAX shingle vaccine and half of the participants will not received anything.

Timeline

Start
2015-05-01
Primary completion
2018-05-01
Completion
2018-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varivax Vaccine 0.65 ml Subcutaneous

Indications